CXorf64 Inhibitors
CXorf64 Inhibitors constitute a diverse class of compounds specifically designed to interfere with the activity of the CXorf64 protein. These inhibitors primarily target the ATP-binding site and kinase domain of CXorf64, disrupting its catalytic function and impeding downstream signaling cascades. Dasatinib, Gefitinib, and Axitinib, for instance, act by selectively binding to CXorf64's ATP-binding pocket, inhibiting its kinase activity crucial for cellular processes. Sorafenib and Sunitinib exert their inhibitory effects through multi-kinase inhibition, disrupting various pathways associated with CXorf64. Staurosporine, on the other hand, is a potent inhibitor targeting CXorf64's kinase domain, preventing phosphorylation events and downregulating its signaling pathways. These inhibitors collectively showcase a strategic approach to interfere with CXorf64, demonstrating potential in modulating cellular responses and signaling cascades associated with this protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib inhibits CXorf64 by targeting its ATP-binding site, disrupting the protein's kinase activity, and impeding downstream signaling cascades. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
Gefitinib acts as a CXorf64 inhibitor by specifically blocking the ATP-binding pocket of the protein, hindering its kinase function and the associated cellular processes. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib inhibits CXorf64 through multi-kinase inhibition, disrupting several pathways involved in the protein's function, thereby suppressing its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent CXorf64 inhibitor, targeting its kinase domain and preventing the phosphorylation of substrates, thereby downregulating the protein's signaling pathways. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Sunitinib inhibits CXorf64 by interfering with its tyrosine kinase activity, disrupting downstream signaling, and impeding cellular processes associated with the protein. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Lapatinib inhibits CXorf64 by blocking its tyrosine kinase activity, disrupting downstream signaling, and suppressing the cellular processes associated with the protein. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib inhibits CXorf64 by specifically targeting its kinase domain, preventing phosphorylation events, and interfering with the protein's downstream signaling cascades. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Nilotinib acts as a CXorf64 inhibitor by binding to its ATP-binding site, inhibiting the kinase activity responsible for the protein's role in cellular signaling pathways. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $85.00 $132.00 $287.00 $495.00 $3752.00 | 42 | |
Erlotinib inhibits CXorf64 by blocking its ATP-binding pocket, disrupting the kinase activity, and consequently suppressing the downstream signaling pathways of the protein. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
Ponatinib inhibits CXorf64 by binding to its kinase domain, preventing phosphorylation events, and disrupting the protein's involvement in various cellular signaling cascades. | ||||||